NEIMETH - Neimeth International Pharma
Neimeth International Pharmaceuticals Plc is the resultant company from the management-buy-out of the 60% equity holding of Pfizer Inc. in Pfizer Products Plc. This management-buy-out took place in May 1997 when Pfizer Inc., in pursuit of its global repositioning strategy, divested 60% equity in Pfizer Products Plc. in favour of the existing management. Before the brand name Neimeth International Pharmaceuticals Plc, the company had operated in Nigeria for 40 years, manufacturing, marketing, and distributing Pfizer brands of pharmaceutical and veterinary products in tablets, capsules, ointment/cream, powder, injectables, and oral liquid forms.
|Last Trading Results||Growth & Valuation|
|Opening Price:||0.96||Earnings Per Share:||-0.13|
|Day's Low Price:||0.92||Price/Earning Ratio:||--|
|Day's High Price:||1.00||Dividend Per Share:||--|
|Traded Volume:||11,530,774||Dividend Yield:||--|
|Number of Deals:||149||Shares Outstanding:||1,726.51m|
Monetary values are quoted in Nigerian Naira (NGN) unless otherwise stated
NEIMETH Market Performance
NEIMETH currently ranks 37th on the Nigerian Stock Exchange in terms of returns to investors with a year-to-date gain of 25.64%. Following NEIMETH are DIAMONDBNK (25.56%), UNILEVER (22.83%), and LINKASSURE (22%). Shareholders are anxiously awaiting when Neimeth International Pharma will announce dividends to see whether they have gained something or not. Below is the historical trading trend of NEIMETH, covering up to the last 10 trading sessions of activity.
Profile of Neimeth International Pharma
Neimeth International Pharma operates in the Health Care sector, specifically, the Pharmaceuticals industry—according to the reverse Industry Classification Benchmark (ICB) taxonomy. The company's board of directors is composed of 11 members whose names are listed below.
- Dr. A. B. C. Orjiako
- E. P. Ekunno
Chief Executive Officer
- Christopher U. Mmeje
- Mazi Sam I. Ohuabunwa
- Godwin E. Omene
- Godfrey N. Ohuabunwa
- A. O. Balogun
- Elijah N. Sokomba
- Maurice M. Iwu
- Thomas Tunbosun Osubu
- Sir. Ike Onyechi
|Factsheet of Neimeth International Pharma|
1 Henry Carr Street, Ikeja Industrial Estate, Ikeja, Lagos 21111, Nigeria
Industrial Stock Market Competitors
Neimeth International Pharma, issuers of the NEIMETH stock on the Nigerian Stock Exchange, have seven market competitors who are also engaged in the Health Care/Pharmaceuticals industry. The table below gives you an overview of their market standing.
|GLAXOSMITH||Glaxo Smithkline Consumer||24.46b||20.45||+0.00|
|MAYBAKER||May & Baker Nigeria||4.65b||4.74||-0.24|
|EVANSMED||Evans Medical Plc||366.17m||0.50||+0.00|